Orchid Pharma Ltd
NSE:ORCHPHARMA

Watchlist Manager
Orchid Pharma Ltd Logo
Orchid Pharma Ltd
NSE:ORCHPHARMA
Watchlist
Price: 1 797.4 INR 4.1% Market Closed
Market Cap: 91.2B INR
Have any thoughts about
Orchid Pharma Ltd?
Write Note

Wall Street
Price Targets

ORCHPHARMA Price Targets Summary
Orchid Pharma Ltd

Wall Street analysts forecast ORCHPHARMA stock price to drop over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ORCHPHARMA is 1 638.12 INR with a low forecast of 1 297.85 INR and a high forecast of 1 914.15 INR.

Lowest
Price Target
1 297.85 INR
28% Downside
Average
Price Target
1 638.12 INR
9% Downside
Highest
Price Target
1 914.15 INR
6% Upside
Orchid Pharma Ltd Competitors:
Price Targets
4886
ASKA Pharmaceutical Holdings Co Ltd
21% Upside
4746
Formosa Laboratories Inc
63% Upside
POLB
Poolbeg Pharma PLC
228% Upside
000513
Livzon Pharmaceutical Group Inc
7% Upside
600867
Tonghua Dongbao Pharmaceutical Co Ltd
38% Upside

Revenue
Forecast

Revenue Estimate
Orchid Pharma Ltd

For the last 8 years the compound annual growth rate for Orchid Pharma Ltd's revenue is -1%. The projected CAGR for the next 3 years is 40%.

-1%
Past Growth
40%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Orchid Pharma Ltd

For the last 8 years the compound annual growth rate for Orchid Pharma Ltd's operating income is 15%. The projected CAGR for the next 2 years is 25%.

15%
Past Growth
25%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Net Income
Forecast

Net Income Estimate
Orchid Pharma Ltd

The compound annual growth rate of Orchid Pharma Ltd's net income for the next 3 years is 69%.

N/A
Past Growth
69%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is ORCHPHARMA's stock price target?
Price Target
1 638.12 INR

According to Wall Street analysts, the average 1-year price target for ORCHPHARMA is 1 638.12 INR with a low forecast of 1 297.85 INR and a high forecast of 1 914.15 INR.

What is Orchid Pharma Ltd's Revenue forecast?
Projected CAGR
40%

For the last 8 years the compound annual growth rate for Orchid Pharma Ltd's revenue is -1%. The projected CAGR for the next 3 years is 40%.

What is Orchid Pharma Ltd's Operating Income forecast?
Projected CAGR
25%

For the last 8 years the compound annual growth rate for Orchid Pharma Ltd's operating income is 15%. The projected CAGR for the next 2 years is 25%.

What is Orchid Pharma Ltd's Net Income forecast?
Projected CAGR
69%

The compound annual growth rate of Orchid Pharma Ltd's net income for the next 3 years is 69%.

Back to Top